KŠB advised the seller on the sale of mcePharma to the Brenntag Group
The acquisition of mcePharma, a company focused on the development and production of innovative food supplements, complementary pet feed, and cosmetics, represents a strategic step for the Brenntag Group to strengthen its presence in the Life Sciences market in the EMEA region.
This was already the second successful sale of a company managed by Mr. Mikeš – we previously represented him in the sale of IMCoPharma to the Barentz Group.
Other articles
KŠB once again assists with ČEZ’s General Meeting
The KŠB team, consisting of Jana Guričová, Martin Kubík and Jan Lasák, led by Petr Kasík, provided legal support to ČEZ in connection with the preparation and conduct of its Annual General Meeting.
DNS – What Now Constitutes a Commonly Available Supply or Service
Professional literature has traditionally compared a dynamic purchasing system (DNS) to a standard online purchase. However, in its judgment No. 22 As 15/2025-65 of 12 May 2026, the Supreme Administrative Court significantly refined this understanding.
KŠB Advised J&T IB and Capital Markets on the 3M FUND MSI SICAV Bond Program
Kocián Šolc Balaštík provided legal advice to J&T IB and Capital Markets, a.s. as the arranger in preparing the base prospectus for 3M FUND MSI SICAV a.s.’s bond program.
